There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Automation
of chemistry at a pharmaceutical company commonly entails
bringing commercial solutions in-house, reproducing manual processes
with a robot, or integrating multiple instruments to eliminate human
intervention. A strategy of industrializing proven approaches, while
financially justifiable, however, does not encourage innovation. On
the other hand, trying to automate unproven or difficult processes
may seem to be risky but can actually accelerate the adoption, modification,
or rejection of novel technologies. Having chemists and engineers
work together to develop automation that accelerates the development
and evaluation of innovative concepts is one blueprint for delivering
a competitive advantage to an organization.
[1
]Integrated Science and Technology (iSAT) Discovery, Specialized Research in Chaotic
Systems (SPaRCS), AbbVie, 1 North Waukegan Road, North Chicago, Illinois 60064-6212,
United States